実践薬学（薬学）

Keyphrases

1. ABCC4 5%
2. Absorption Rate 11%
3. Acute Renal Failure 11%
4. Amiodarone 11%
5. Anticoagulant Effect 10%
6. Apparent Volume of Distribution 6%
7. Bisoprolol 30%
8. Bosentan 20%
9. Caco-2 Cells 27%
10. Carvedilol 58%
11. Carvedilol Enantiomers 15%
12. Cisplatin-induced 5%
13. CYP2C19 8%
14. CYP2C9 11%
15. CYP2D6 Genotype 7%
16. CYP2D6*10 24%
17. CYP3A5 7%
18. Cytochrome P450 1A1 (CYP1A1) 5%
19. Cytochrome P450 2D6 (CYP2D6) 16%
20. Cytochrome P450 3A (CYP3A) 6%
21. Cytochrome P450 3A4 (CYP3A4) 11%
22. Dose Requirement 5%
23. Dose-response Relationship 11%
24. Drug Concentration 9%
25. Elimination Half-life 10%
26. Flecainide 5%
27. Genetic Polymorphism 7%
28. Genotype 15%
29. Glucuronidation 21%
30. Heart Failure 8%
31. Hepatic Extraction 11%
32. Human Liver Microsomes 17%
33. Human Serum Proteins 5%
34. Incubation 8%
35. Inducible Enzymes 5%
36. Inhibitory Effect 9%
37. Intensive Care Unit 5%
38. Inter-individual Variability 9%
39. Intestinal Absorption 31%
40. Intestinal Epithelial Cells 29%
41. Intestinal Microsomes 5%
42. Japanese children 11%
43. Japanese Patients 44%
44. Japanese Pediatric Patients 8%
45. Japanese Workers 17%
46. Levofloxacin 11%
47. Ligation 16%
48. LLC-PK1 6%
49. LLC-PK1 Cells 8%
50. LS180 Cell 32%
51. Maturation Function 5%
52. Membrane Transport Mechanism 11%
53. Metabolism 19%
54. Metoprolol 35%
55. Mizoribine 18%
56. Na + 11%
57. NONMEM 20%
58. Nucleoside Transporters 6%
59. Old Japanese 14%
60. Oral Administration 6%
61. Oral Clearance 30%
62. P-glycoprotein (P-gp) 19%
63. Patients with Heart Failure 6%
64. Peak Concentration 5%
65. Pharmacokinetic Parameters 7%
66. Pharmacokinetic Variability 34%
67. Pharmacokinetics 69%
68. Phosphodiesterase Type 5 Inhibitors 7%
69. Plasma Concentration 21%
70. Polymorphism 8%
71. Population Pharmacokinetics 6%
72. Procainamide 6%
73. Propranolol 6%
74. Protein Binding 6%
75. Pulmonary Arterial Hypertension 9%
76. Quinidine 14%
77. Rat Intestine 11%
78. Regression Analysis 7%
79. Renal Excretion 7%
80. Renal Failure 12%
81. Repeated Dose 11%
82. Ribavirin 6%
83. Sampling Design 15%
84. Sildenafil 18%
85. Stereoselective Metabolism 11%
86. Stereoselective Oxidation 5%
87. Systemic Clearance 11%
88. Tadalafil 23%
89. Temperature Effect 7%
90. Tetraethylammonium 5%
91. Transcellular Transport 12%
92. Trough Concentration 8%
93. UGT2B7 8%
94. Unbound Fraction 8%
95. Uptake Transporter 6%
96. Ureter 17%
97. Vitamin K Epoxide Reductase 12%
98. Warfarin 20%
99. Warfarin Dose 5%
100. α-Naphthoflavone 11%

Pharmacology, Toxicology and Pharmaceutical Science

1. Acute Kidney Failure 11%
2. Allergic Reaction 5%
3. Amiodarone 11%
4. Anticoagulant Agent 7%
5. Bepridil 5%
6. Bioavailability 24%
7. Bisoprolol 30%
8. Bosentan 14%
9. Bovine Serum Albumin 5%
10. Carvedilol 53%
11. Cisplatin 5%
12. Congestive Heart Failure 16%
13. CYP2C19 10%
14. CYP2C9 7%
15. CYP2D6 34%
16. CYP3A 6%
17. CYP3A4 11%
18. Cytochrome P450 11%
19. Cytochrome P450 1A 5%
20. Cytochrome P450 3A5 9%
21. Dose-Response Relationship 11%
22. Drug Concentration 7%
23. Effusion 5%
24. Elimination 15%
25. Flecainide 5%
26. Glycylsarcosine 5%
27. Heart Arrhythmia 5%
28. Histamine 5%
29. Hypoxia 5%
30. Kidney Failure 13%
31. Lansoprazole 5%
32. Levofloxacin 11%
33. Liver Dysfunction 5%
34. Maintenance Dose 5%
35. Messenger RNA 9%
36. Metoprolol 35%
37. Mizoribine 12%
38. Nucleoside 5%
39. P-Glycoprotein 19%
40. Paraquat 5%
41. Pharmacodynamics 5%
42. Pharmacogenetics 5%
43. Pharmacokinetic Parameter 5%
44. Pharmacokinetics 100%
45. Phenthoate 5%
46. Phosphodiesterase V Inhibitor 5%
47. Plasma Protein 5%
48. Procainamide 6%
49. Propranolol 6%
50. Protein Binding 6%
51. Protein Losing Gastroenteropathy 5%
52. Proton Pump 5%
53. Pulmonary Hypertension 9%
54. Quinidine 13%
55. Reduced Nicotinamide Adenine Dinucleotide Phosphate 7%
56. Renal Excretion 7%
57. Ribavirin 6%
58. Risperidone 5%
59. Sildenafil 18%
60. Sodium Ion 11%
61. Table Salt 5%
62. Tacrolimus 5%
63. Tadalafil 23%
64. Tetrylammonium 5%
65. Therapeutic Effect 5%
66. Toxicity 5%
67. Transcellular Transport 12%
68. Transcytosis 12%
69. Vitamin D Receptor 5%
70. Vitamin K Epoxide Reductase 6%
71. Volume of Distribution 6%
72. Warfarin 20%